Hecla Mining Company Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Hecla Mining Company Common Stock trades at $17.21 (market cap $11.24B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.71 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 5.2× Hecla Mining Company Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold Hecla Mining Company Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| HL | TAK | |
|---|---|---|
Market Cap | $11.24B | $58.74B |
Volume | 37,227,749 | 3,110,994 |
Sector | Basic Materials | Health |
52-Week High | $31.81 | $19.05 |
52-Week Low | $11.97 | $13.23 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.77B | $86.65B |
Dividend Yield | 0.09% | 3.33% |
Trailing returns across standard periods
Latest headlines on both assets
Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.
Read more on HL →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →